Debt-to-equity of Larimar Therapeutics, Inc. from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Larimar Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Larimar Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 23%, a 114% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Larimar Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 23% +12% +114% 30 Sep 2025
Q2 2025 17% +5.4% +49% 30 Jun 2025
Q1 2025 14% +3.1% +28% 31 Mar 2025
Q4 2024 11% -1.8% -13% 31 Dec 2024
Q3 2024 11% -1.7% -14% 30 Sep 2024
Q2 2024 11% -1.3% -11% 30 Jun 2024
Q1 2024 11% -3.5% -25% 31 Mar 2024
Q4 2023 13% -3.8% -22% 31 Dec 2023
Q3 2023 12% -6.6% -35% 30 Sep 2023
Q2 2023 12% -11% -47% 30 Jun 2023
Q1 2023 14% -7.7% -35% 31 Mar 2023
Q4 2022 17% -3.6% -17% 31 Dec 2022
Q3 2022 19% +0.14% +0.74% 30 Sep 2022
Q2 2022 23% +7.5% +47% 30 Jun 2022
Q1 2022 22% +8.1% +58% 31 Mar 2022
Q4 2021 20% +0.18% +0.89% 31 Dec 2021
Q3 2021 19% -5.5% -22% 30 Sep 2021
Q2 2021 16% -49% -75% 30 Jun 2021
Q1 2021 14% -2325% -99% 31 Mar 2021
Q4 2020 20% -3295% -99% 31 Dec 2020
Q3 2020 24% -1816% -99% 30 Sep 2020
Q2 2020 64% -42% -40% 30 Jun 2020
Q1 2020 2339% +2269% +3241% 31 Mar 2020
Q4 2019 3315% +3265% +6533% 31 Dec 2019
Q3 2019 1840% +1803% +4874% 30 Sep 2019
Q2 2019 107% +75% +239% 30 Jun 2019
Q1 2019 70% +49% +227% 31 Mar 2019
Q4 2018 50% +36% +262% 31 Dec 2018
Q3 2018 37% +29% +349% 30 Sep 2018
Q2 2018 32% +23% +262% 30 Jun 2018
Q1 2018 21% +13% +148% 31 Mar 2018
Q4 2017 14% +4.6% +50% 31 Dec 2017
Q3 2017 8.2% -1.9% -19% 30 Sep 2017
Q2 2017 8.7% -1.4% -13% 30 Jun 2017
Q1 2017 8.6% -1.1% -11% 31 Mar 2017
Q4 2016 9.2% +0.43% +4.9% 31 Dec 2016
Q3 2016 10% +1.6% +18% 30 Sep 2016
Q2 2016 10% +0.27% +2.8% 30 Jun 2016
Q1 2016 9.7% -0.63% -6.1% 31 Mar 2016
Q4 2015 8.8% 31 Dec 2015
Q3 2015 8.6% 30 Sep 2015
Q2 2015 9.8% 30 Jun 2015
Q1 2015 10% 31 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.